New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm
Yogendra Kanthi, Jason S. Knight, Yu Zuo, David J. Pinsky
Abstract
Purinergic signaling is discussed as a potential therapeutic target to reduced COVID-19 severity.
Topics & Concepts
Purinergic receptorCoronavirus disease 2019 (COVID-19)Drug2019-20 coronavirus outbreakPharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyInternal medicineReceptorInfectious disease (medical specialty)DiseaseOutbreakCOVID-19 Clinical Research StudiesVagus Nerve Stimulation ResearchAdenosine and Purinergic Signaling